260 related articles for article (PubMed ID: 29991274)
1. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
Penot P; Héma A; Bado G; Sombié D; Kaboré FN; Poda A; Michon C; Terzolo O; Traoré A; Slama L; Sawadogo A; Laurent C
AIDS Care; 2018 Dec; 30(12):1502-1506. PubMed ID: 29991274
[TBL] [Abstract][Full Text] [Related]
2. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.
Penot P; Héma A; Bado G; Kaboré F; Soré I; Sombié D; Traoré JR; Guiard-Schmid JB; Fontanet A; Slama L; Bruno Sawadogo A; Laurent C
J Int AIDS Soc; 2014; 17(1):18646. PubMed ID: 24433983
[TBL] [Abstract][Full Text] [Related]
3. Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.
Li JZ; Gallien S; Ribaudo H; Heisey A; Bangsberg DR; Kuritzkes DR
AIDS; 2014 Jan; 28(2):181-186. PubMed ID: 24361679
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of Low-Level Persistent viraemias in HIV-1 Patients Treated with Second-Line ARVs at the Sourô Sanou Teaching Hospital of Bobo-Dioulasso (Burkina Faso)].
Zoungrana J; Kyelem CG; Sondo KA; Naibi KA; Hema A; Kabore NF; Poda A; Bado A; Yaméogo I; Séré H; Ouedraogo AS; Tani S; Tarnagda Z
Bull Soc Pathol Exot; 2018; 111(3):161-166. PubMed ID: 30793572
[TBL] [Abstract][Full Text] [Related]
5. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.
DiPrete BL; Pence BW; Golin CE; Knight K; Flynn PM; Carda-Auten J; Groves JS; Powers KA; White BL; Napravnik S; Wohl DA
AIDS Behav; 2019 Sep; 23(9):2386-2395. PubMed ID: 30963321
[TBL] [Abstract][Full Text] [Related]
7. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.
Nyaku M; Beer L; Shu F
AIDS Care; 2019 May; 31(5):599-608. PubMed ID: 30309269
[TBL] [Abstract][Full Text] [Related]
8. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
Meresse M; March L; Kouanfack C; Bonono RC; Boyer S; Laborde-Balen G; Aghokeng A; Suzan-Monti M; Delaporte E; Spire B; Carrieri MP; Laurent C;
HIV Med; 2014 Sep; 15(8):478-87. PubMed ID: 24589279
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.
Atuhaire P; Hanley S; Yende-Zuma N; Aizire J; Stranix-Chibanda L; Makanani B; Milala B; Cassim H; Taha T; Fowler MG
PLoS One; 2019; 14(10):e0219415. PubMed ID: 31647806
[TBL] [Abstract][Full Text] [Related]
10. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
[TBL] [Abstract][Full Text] [Related]
11. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
[TBL] [Abstract][Full Text] [Related]
12. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
[TBL] [Abstract][Full Text] [Related]
13. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
15. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
16. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.
Musinguzi N; Mocello RA; Boum Y; Hunt PW; Martin JN; Haberer JE; Bangsberg DR; Siedner MJ
AIDS Behav; 2017 Jun; 21(6):1735-1740. PubMed ID: 27256394
[TBL] [Abstract][Full Text] [Related]
17. The Modalities of Nonadherence to Highly Active Antiretroviral Therapy and the Associated Factors Related to Patients' Sociodemographic Characteristics and Their Caregiving Perceptions in Ouagadougou (Burkina Faso).
Guira O; Kaboré DS; Dao G; Zagré N; Zohoncon TM; Pietra V; Drabo JY; Simporé J
J Int Assoc Provid AIDS Care; 2016 May; 15(3):256-60. PubMed ID: 26567225
[TBL] [Abstract][Full Text] [Related]
18. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam.
Huong DT; Bannister W; Phong PT; Kirk O; Peters L
Int J STD AIDS; 2011 Nov; 22(11):659-64. PubMed ID: 22096052
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
Bucek A; Leu CS; Benson S; Warne P; Abrams EJ; Elkington KS; Dolezal C; Wiznia A; Mellins CA
Pediatr Infect Dis J; 2018 Jul; 37(7):673-677. PubMed ID: 29227462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
